Evidence map›Paper›PMID 40422969›Full record

ArticleThe Journal of organic chemistry2025

Protective Group-Dependent Iridium-Catalyzed CH Borylations of Levodopa.

Cliff Yang, Jinda Fan, Robert E Maleczka

Abstract read
In one paragraph

Article in The Journal of organic chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cliff YangDepartment of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, Michigan 48824, United States.
Jinda FanDepartment of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, Michigan 48824, United States.ORCID 0000-0003-3098-3397
Robert E MaleczkaDepartment of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, Michigan 48824, United States.ORCID 0000-0002-1119-5160

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite being an important aromatic amino acid, iridium-catalyzed borylation (CHB) of levodopa has not been reported. Via the application of carefully chosen protecting groups for the catechol moiety, the steric hindrance around the arene can be reduced, enabling selective C5 CHB of levodopa. Methylene and boronic ester protecting groups were explored, the latter of which is deprotected in situ to yield the free catechol.

Indexed as

Boron CompoundsIridiumLevodopaCatalysisMolecular StructureBoron CompoundsIridiumLevodopa

Identifiers

PMID40422969
PMCPMC12150333

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.